Head of Programs & Portfolio Management
Julianne Bruno has served as our Senior Vice President and Head of Programs & Portfolio Management at CRISPR Therapeutics since March 2023. During her time at CRISPR Therapeutics, she has held several different positions, including leading the hemoglobinopathy partnership program with Vertex through the early clinical stage through present day. In addition, Julianne is responsible for overseeing the immuno-oncology trials and program management function, which spans across all of the program areas (hemoglobinopathies, immuno-oncology, regenerative medicine, in vivo) and partnerships. Before joining CRISPR Therapeutics, Julianne worked at McKinsey & Company where she was a leader in the biotech practice and served a number of biotechnology companies on a wide range of commercial topics. Julianne received her M.B.A. from The Wharton School and also holds an A.B. from Princeton University.
You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.